Skip to main content

Chris Mazza, former CEO of Ornge, in November, 2012.

Fernando Morales/The Globe and Mail

Taxpayer dollars going to for-profit companies, incomplete documents and the absence of approval for a loan to Ornge's ousted CEO Chris Mazza were among the findings of a team of auditors who combed through the troubled air ambulance's books.

Ornge's for-profit entities got public dollars from the publicly funded air ambulance service, said Allen Tait, the director of the government audit team. "We did not identify a regular source of revenue that was not ministry-related," he told a legislative committee.

About 93.5 per cent of the total money going to the conglomerate came from the government, he said. The remainder was borrowed or donated money, tax rebates and funds from a controversial deal involving Ornge's headquarters.

Story continues below advertisement

Ontario's auditor-general found that one of Ornge's for-profit subsidiaries bought a building for $15-million, then leased it back to the publicly funded agency at a rate that was 40 per cent higher than fair-market rent.

That allowed the subsidiary to obtain $24-million in financing for the building, $9-million of which was intended to flow back to a related for-profit company that was owned by a senior Ornge manager.

Mr. Tait said his team identified 20 for-profit companies created by Ornge, which gets about $150-million a year from the province. Those entities are now being wound down.

Some were owned by ousted CEO Chris Mazza, other executives and the board of directors, according to auditor-general Jim McCarter.

His report last year criticized the governing Liberals for failing to oversee Ornge despite giving it $730-million over five years and allowing it to borrow almost $300-million more in 2009.

Mr. Tait said his team mapped out Ornge's corporate structure and spent a "significant" amount of time documenting the board membership of each entity. They identified who belonged to which board, so when they looked at the cash flow, they "could see the extent of, shall we say, common interest," he said. "There were some board members who were on a significant number of the 20 entities in the conglomerate. We didn't find anyone who was on all 20. What we did find, certainly some who were on more than half."

Some of the directors were given shares in the companies and there was an expectation that by sitting on their boards, they would profit, Progressive Conservative Frank Klees said.

Story continues below advertisement

"And they profit at the expense of taxpayers in the province of Ontario," he said.

Mr. Tait said his team also looked at the three loans totalling $1.2-million that Mr. Mazza collected in a single year on top of the $1.4 million he got in salary and bonuses.

Mr. Mazza got a $500,000 housing loan in July, 2010, $250,000 from Ornge Global as an advance on his bonus, and another $450,000 from Ornge Global in July, 2011.

The documents supporting the loans were "inconsistent," he told the committee.

"We did have a situation where one of the documents there appeared to be a form of approval from the board, there appeared to be email approval on one, and to the best of my recollection, one we did not find any evidence of approval," Mr. Tait said.

He would not comment after his appearance before the committee about which of the three loans lacked approval.

Story continues below advertisement

The Ministry of Health asked the audit team to do a forensic audit of Ornge's books from 2007 to 2012. But Mr. Tait would not go beyond an overview of the findings, saying he did not want to compromise the criminal investigation by the Ontario Provincial Police, who have the report.

The police have said it could be another year before charges, if any, are laid.

Mr. Klees said Mr. Tait confirmed what the committee had suspected during the course of their hearings on Ornge.

"We've been told repeatedly by these directors, by the chair of the board, that any of the funds that flowed into these companies came from outside investments, were not co-mingled with Ministry of Health funds," he said. "That is simply not the case."

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter